773100-76-8 Usage
Description
5-Bromomethyl-2-fluorobenzoic acid is an organic compound characterized by the presence of a bromomethyl group at the 5th position and a fluorine atom at the 2nd position on a benzoic acid backbone. This unique molecular structure endows it with specific chemical properties and potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
5-Bromomethyl-2-fluorobenzoic acid is used as an aminocarboxymuconate semialdehyde decarboxylase inhibitor for its ability to modulate the activity of this enzyme. This makes it a potential candidate for the development of drugs targeting metabolic pathways and conditions where the inhibition of aminocarboxymuconate semialdehyde decarboxylase can be therapeutically beneficial.
Check Digit Verification of cas no
The CAS Registry Mumber 773100-76-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,3,1,0 and 0 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 773100-76:
(8*7)+(7*7)+(6*3)+(5*1)+(4*0)+(3*0)+(2*7)+(1*6)=148
148 % 10 = 8
So 773100-76-8 is a valid CAS Registry Number.
773100-76-8Relevant articles and documents
Five-membered or six-membered heterocyclic pyrimidine compound and applications thereof
-
Paragraph 0391-0398, (2020/05/08)
The invention relates to a five-membered or six-membered heterocyclic pyrimidine compound for treating diseases responsive to activation of a TLR7 receptor, and a pharmaceutical composition.
Design, synthesis and identification of novel colchicine-derived immunosuppressant
Chang, Dong-Jo,Yoon, Eun-Young,Lee, Geon-Bong,Kim, Soon-Ok,Kim, Wan-Joo,Kim, Young-Myeong,Jung, Jong-Wha,An, Hongchan,Suh, Young-Ger
scheme or table, p. 4416 - 4420 (2010/04/05)
Synthesis and biological evaluation of various colchicine analogues through the mixed-lymphocyte reaction (MLR), lymphoproliferation, and inhibitory effects on the inflammatory genes are described. In addition, a new series of immunosuppressive agents developed on the structural basis of colchicine, as well as their structure-activity relationships is reported. The most potent analogue 20a exhibited an excellent immunosuppressive activity on in vivo skin-allograft model, which is comparable to that of cyclosporin A.
